Great Point Partners as of Sept. 30, 2021
Portfolio Holdings for Great Point Partners
Great Point Partners holds 36 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Exelixis (EXEL) | 7.5 | $32M | 1.5M | 21.14 | |
| Arena Pharmaceuticals Com New | 7.4 | $32M | 531k | 59.55 | |
| Kadmon Hldgs | 6.8 | $29M | 3.4M | 8.71 | |
| Bioatla (BCAB) | 5.8 | $25M | 844k | 29.44 | |
| Rocket Pharmaceuticals (RCKT) | 5.3 | $23M | 765k | 29.89 | |
| Macrogenics (MGNX) | 4.9 | $21M | 1.0M | 20.94 | |
| Dicerna Pharmaceuticals | 3.8 | $16M | 800k | 20.16 | |
| United Therapeutics Corporation (UTHR) | 3.7 | $16M | 87k | 184.58 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.6 | $15M | 85k | 181.39 | |
| Travere Therapeutics (TVTX) | 3.5 | $15M | 625k | 24.25 | |
| Anaptysbio Inc Common (ANAB) | 3.5 | $15M | 550k | 27.12 | |
| Cytokinetics Com New (CYTK) | 3.3 | $14M | 391k | 35.74 | |
| Biogen Idec (BIIB) | 3.1 | $13M | 48k | 282.99 | |
| Urogen Pharma (URGN) | 2.9 | $13M | 750k | 16.82 | |
| Dyne Therapeutics (DYN) | 2.8 | $12M | 745k | 16.24 | |
| Sage Therapeutics (SAGE) | 2.8 | $12M | 269k | 44.31 | |
| Xenon Pharmaceuticals (XENE) | 2.5 | $11M | 700k | 15.28 | |
| Tricida | 2.1 | $9.2M | 2.0M | 4.64 | |
| Puma Biotechnology (PBYI) | 2.1 | $9.1M | 1.3M | 7.01 | |
| Olema Pharmaceuticals (OLMA) | 2.1 | $9.1M | 329k | 27.56 | |
| Nektar Therapeutics (NKTR) | 2.1 | $9.1M | 505k | 17.96 | |
| Aclaris Therapeutics (ACRS) | 2.1 | $9.0M | 500k | 18.00 | |
| Rafael Hldgs Com Cl B (RFL) | 2.0 | $8.8M | 286k | 30.73 | |
| Magenta Therapeutics | 2.0 | $8.5M | 1.2M | 7.28 | |
| Cytomx Therapeutics (CTMX) | 1.8 | $7.6M | 1.5M | 5.09 | |
| Rigel Pharmaceuticals Com New (RIGL) | 1.7 | $7.2M | 2.0M | 3.63 | |
| Aeglea Biotherapeutics | 1.7 | $7.2M | 900k | 7.95 | |
| Phathom Pharmaceuticals (PHAT) | 1.7 | $7.1M | 221k | 32.10 | |
| Apellis Pharmaceuticals Call Option (APLS) | 1.5 | $6.6M | 200k | 32.96 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 1.3 | $5.5M | 480k | 11.39 | |
| Vaxcyte (PCVX) | 0.6 | $2.5M | 98k | 25.37 | |
| Repare Therapeutics Ord (RPTX) | 0.6 | $2.4M | 93k | 26.24 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.6 | $2.4M | 121k | 19.74 | |
| Amicus Therapeutics (FOLD) | 0.6 | $2.4M | 249k | 9.55 | |
| Inflarx Nv (IFRX) | 0.3 | $1.4M | 552k | 2.59 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $254k | 30k | 8.37 |
